Competition between CTL narrows the immune response induced by prime-boost vaccination protocols.

Competition between CTL narrows the immune response induced by prime-boost vaccination protocols.

Recombinant vaccines encoding strings of virus- or tumor-derived peptides and/or proteins are currently being designed for use against both cancer and infectious diseases. These vaccines aim to induce cytotoxic immune responses against several Ags simultaneously. We developed a novel tetramer-based...

Detaylı Bibliyografya
Asıl Yazarlar:	Palmowski, M, Choi, E, Hermans, I, Gilbert, S, Chen, J, Gileadi, U, Salio, M, Van Pel, A, Man, S, Bonin, E, Liljestrom, P, Dunbar, P, Cerundolo, V
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2002

Benzer Materyaller

The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo.
Yazar:: Hermans, I, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

High avidity antigen-specific CTL identified by CD8-independent tetramer staining.
Yazar:: Choi, E, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens.
Yazar:: Salio, M, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Intravenous injection of a lentiviral vector encoding NY-ESO-1 induces an effective CTL response.
Yazar:: Palmowski, M, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.
Yazar:: Smith, C, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Mature dendritic cells prime functionally superior melan-A-specific CD8+ lymphocytes as compared with nonprofessional APC.
Yazar:: Salio, M, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

The use of HLA class I tetramers to design a vaccination strategy for melanoma patients.
Yazar:: Palmowski, M, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara.
Yazar:: Smith, C, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Viral immunity: cross-priming with the help of TLR3.
Yazar:: Salio, M, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.
Yazar:: Gileadi, U, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.
Yazar:: Chen, J, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Role of the proteasome and non proteasomal proteases in the generation of CTL epitopes.
Yazar:: Cerundolo, V, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Modulation of CD103 expression on human colon carcinoma-specific CTL.
Yazar:: Ling, K, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6.
Yazar:: Evans, M, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS.
Yazar:: Hanke, T, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Plasmacytoid dendritic cells prime IFN-gamma-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions.
Yazar:: Salio, M, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response.
Yazar:: Dunbar, P, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

CTL priming by CD8(+) and CD8(-) dendritic cells in vivo.
Yazar:: Ruedl, C, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma.
Yazar:: Dunbar, P, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes.
Yazar:: Ogg, G, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Dendritic cells: a journey from laboratory to clinic.
Yazar:: Cerundolo, V, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Construction and immunogenicity in a prime-boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine.
Yazar:: Hanke, T, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent.
Yazar:: Whelan, J, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara.
Yazar:: Sharpe, S, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells.
Yazar:: Hermans, I, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming.
Yazar:: Plebanski, M, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Role of immunoproteasomes in cross-presentation.
Yazar:: Palmowski, M, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies.
Yazar:: Schneider, J, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma model.
Yazar:: Hermans, I, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Co- but not Sequential Infection of DCs Boosts Their HIV-Specific CTL-Stimulatory Capacity
Yazar:: Manuela Schönfeld, ve diğerleri
Baskı/Yayın Bilgisi: (2019-05-01)

Differences in phenotype and function between spontaneously occurring melan-A-, tyrosinase- and influenza matrix peptide-specific CTL in HLA-A*0201 melanoma patients.
Yazar:: Maczek, C, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy.
Yazar:: Hill, A, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Novel dual role of dendritic cells in priming de novo CTL responses while inhibiting memory CTL responses to HIV-1 through the PD-L1 pathway
Yazar:: T.M. Garcia-Bates, ve diğerleri
Baskı/Yayın Bilgisi: (2017-12-01)

Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region.
Yazar:: Wooldridge, L, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Mature dendritic cells differentiated in the presence of interferon-beta and interleukin-3 prime functional antigen-specific CD8 T cells.
Yazar:: Renneson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Efficient priming of antigen-specific cytotoxic T lymphocytes by human cord blood dendritic cells.
Yazar:: Salio, M, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting.
Yazar:: Rollier, C, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Dynamics of 8G12 competitive antibody in “prime-boost” vaccination of Hepatitis E vaccine
Yazar:: Xing Wu, ve diğerleri
Baskı/Yayın Bilgisi: (2017-06-01)

Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors.
Yazar:: Zhang, J, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Prime-boost vectored malaria vaccines: progress and prospects.
Yazar:: Hill, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)